The groundbreaking therapy of the medication represents a major development in the management of type 2 diabetes. Distinct from existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 https://tirzepatidepeptide617402.designi1.com/62728029/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment